Diagnostic markers of lung cancer in bronquial fluid: Development of inmunoassays and validation

S. Pedrero, N. Marina, A. Gomez, B. Ruiz-Argüello, M. Uribarri, J. Algorta, S. Carrera, G. López Vivanco, R. Zalacain (Barakaldo, Zamudio, Spain)

Source: Annual Congress 2010 - Biomarkers for lung cancer
Session: Biomarkers for lung cancer
Session type: Thematic Poster Session
Number: 3239
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Pedrero, N. Marina, A. Gomez, B. Ruiz-Argüello, M. Uribarri, J. Algorta, S. Carrera, G. López Vivanco, R. Zalacain (Barakaldo, Zamudio, Spain). Diagnostic markers of lung cancer in bronquial fluid: Development of inmunoassays and validation. Eur Respir J 2010; 36: Suppl. 54, 3239

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Validation of diagnostic molecular markers in bronchial fluid for lung cancer
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011


Potential lung cancer biomarkers from bronchoalveolar lavage fluid using metabolomics approaches
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016


Diagnostic value of bronchoscopic methods in lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 514s
Year: 2006

Diagnostic utility of cell block method combined with conventional smear cytology in the diagnosis of exudative pleural effusions accompanying lung cancer
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


Serum and bronchial aspiration fluid HE-4 levels in lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015

The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013



Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015



Prognostic validation of cryobiopsy for the diagnosis of interstitial lung diseases
Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound
Year: 2019

Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC)
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009

Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Comparison analysis of malignant and tuberculous pleural fluid using proteomic method
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015


Utility of Immunohistochemical markers on EBUS TBNA samples in Specific Diagnostic Subtyping and multiple gene analyses in Primary and Metastatic Lung Cancer – Indian Study
Source: International Congress 2019 – Interventional pulmonology: endobronchial ultrasound-transbronchial needle aspiration
Year: 2019

The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP)
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013


Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging
Source: Annual Congress 2013 –New frontiers for EBUS-TBNA: the mediastinum and beyond
Year: 2013


Bronchoscopic semantics and diagnosis of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013

Diagnostic value of tumor markers and cells population in bronchoalveolar lavage in lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 37s
Year: 2003

Prevalence of preinvasive bronchial lesions in patients with lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013